Show simple item record

dc.contributor.authorLandsberger, M
dc.contributor.authorGandon, S
dc.contributor.authorMeaden, S
dc.contributor.authorRollie, C
dc.contributor.authorChevallereau, A
dc.contributor.authorChabas, H
dc.contributor.authorBuckling, A
dc.contributor.authorWestra, ER
dc.contributor.authorvan Houte, S
dc.date.accessioned2018-09-28T14:13:26Z
dc.date.issued2018-07-19
dc.description.abstractSome phages encode anti-CRISPR (acr) genes, which antagonize bacterial CRISPR-Cas immune systems by binding components of its machinery, but it is less clear how deployment of these acr genes impacts phage replication and epidemiology. Here, we demonstrate that bacteria with CRISPR-Cas resistance are still partially immune to Acr-encoding phage. As a consequence, Acr-phages often need to cooperate in order to overcome CRISPR resistance, with a first phage blocking the host CRISPR-Cas immune system to allow a second Acr-phage to successfully replicate. This cooperation leads to epidemiological tipping points in which the initial density of Acr-phage tips the balance from phage extinction to a phage epidemic. Furthermore, both higher levels of CRISPR-Cas immunity and weaker Acr activities shift the tipping points toward higher initial phage densities. Collectively, these data help elucidate how interactions between phage-encoded immune suppressors and the CRISPR systems they target shape bacteria-phage population dynamics.en_GB
dc.description.sponsorshipM.L. was supported by funding from the Wellcome Trust (https://wellcome.ac.uk) (109776/Z/15/Z), which was awarded to E.R.W. E.R.W. further acknowledges the Natural Environment Research Council (https://nerc.ukri.org) (NE/M018350/1), the BBSRC (BB/N017412/1), and the European Research Council (https://erc.europa.eu) (ERC-STG-2016-714478 - EVOIMMECH) for funding. S.v.H. acknowledges funding from the People Programme (Marie Curie Actions; https://ec.europa.eu/research/mariecurieactions/) of the European Union’s Horizon 2020 (REA grant agreement no. 660039) and from the BBSRC (BB/R010781/1). S.G. acknowledges funding (Visiting Professorship) from the Leverhulme Trust. A.B. acknowledges funding from the Royal Society. The authors thank Olivier Fradet for experimental contributions and Adair Borges and Joe Bondy-Denomy (UCSF) for providing DMS3mvir-AcrIF4 and phage JBD26.en_GB
dc.identifier.citationVol. 174 (4), pp. 908 - 916.e12en_GB
dc.identifier.doi10.1016/j.cell.2018.05.058
dc.identifier.urihttp://hdl.handle.net/10871/34137
dc.language.isoenen_GB
dc.publisherElsevier (Cell Press)en_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/30033365en_GB
dc.rights© 2018 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).en_GB
dc.subjectAllee effecten_GB
dc.subjectCRISPR-Casen_GB
dc.subjectanti-CRISPRen_GB
dc.subjectbacteriaen_GB
dc.subjectbifurcationen_GB
dc.subjectepidemiologyen_GB
dc.subjectimmunosuppressionen_GB
dc.subjectpartial resistanceen_GB
dc.subjectphageen_GB
dc.subjecttipping pointsen_GB
dc.titleAnti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunityen_GB
dc.typeArticleen_GB
dc.date.available2018-09-28T14:13:26Z
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the final version of the article. Available from Elsevier via the DOI in this record.en_GB
dc.identifier.journalCellen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record